Search Results for Clinical Trials
Your search produced 65 clinical trials for cancer.View the clinical trial details for a full description of the study.
|
Neuropsychologic, Social, Emotional and Behavioral Outcomes in Children with Cancer (ALTE07C1)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
An Evaluation of Epothilone-B in the Treatment of Recurrent or Persistent (and Paclitaxel Unresponsive) Ovarian or Primary Peritoneal Cancer. (GOG 126-M)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Phase III Study of SU011248 in Combination with Paclitaxel vs, Bevacizumab with Paclitaxel as First Line Treatment for Patients with Advanced Breast Cancer (475-07)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Phase 3 Randomized Trial of Adjuvant Chemotherapy with or without Avastin for Patients with Completely Removed Stage 1B non-small-cell Lung Cancer (NSCLC) (ECOG 1505)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Pilot Study of Intravesical Administration of EOquin immediately following transurethral tumor removal in patients with superficial bladder cancer (350-06s)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
Molecular Genetic Studies of Cancer Patients and their Relatives (354-06s)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Study of Unilateral Retinoblastoma with and without Histopathologic High Risk Features and the Role of Adjuvant Chemotherapy (COG ARET0332)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
Treatment of Newly Diagnosed, Higher Risk, Favorable Histology Wilms Tumor (COG AREN0533)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
Phase II Trial of Ixabepilone in Children and Young Adults with Solid Tumors that have not responded to Treatment (COG ADVL0524)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Phase II Study of Irinotecan and Temozolamide in Children with recurrent Neuroblastoma (COG ANBL0421)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
Phase II Evaluation of Topotecan in the Treatment of Persistent or Recurrent Cervical Cancer (GOG 127-U)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Study of Clinical Outcomes of "Assay Directed Chemotherapy" in the Treatment of Newly Diagnosed, Progressive, or Recurrent Solid Tumor and Hematologic Malignancies in Adults (408-06)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
Pilot Study of Oral Limonene & Lovastatin in Refractory Cancers. (018-00)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
Dose-Dense Adjuvant Chemotherapy plus Bevacizumab in Lymph Node Positive Breast Cancer: a Pilot Study (421-07)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Phase I/II Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer (425-07)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Double-Blind Study of Sorafenib compared to Placebo when given with Chemotherapy for Subjects with Locally Advanced or Metastatic Breast Cancer that has Progressed during or after Bevacizumab Therapy (471-07)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Clinical Trial Comparing 16-18 Weeks of daily Exemestane, Letrozole, or Anastrozole in Postmenopausal Women with Stage II and III Estrogen Receptor Positive Breast Cancer (ACOSOG Z1031)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Study to Evaluate the Long-term Impact of Identifying Tumor-draining Lymph Nodes using Lymphoseek in Patients with known Melanoma or Breast Cancer (529-08s)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Prospective Open-Label Comparison of Lymphoseek and Vital Blue Dye as Lymphoid Tissue Targetting Agents in Patients with known Melanoma or Breast Cancer who are Undegoing Lymph Node Mapping (517-08s)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
HEADSTART III: Dose Intensive Chemotherapy for Children < 10 years of age with Newly-Diagnosed Malignant Brain Tumors: A Pilot Study of Two Intensive Induction Chemotherapy regimens, Followed by Consolidation with Myeloablative Chemotherapy and Autologous (395-06)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
An Extended Trial of Carboplatin, Paclitaxel and Bevacizumab in Women with newly diagnosed, previously untreated, advanced stage Ovarian or Fallopian Tube Cancer (GOG 218)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A GeneBank(TM) Study - The Discovery and Evaluation of Biomarkers for the Prediction, Diagnosis, and Management of Colorectal Cancer, #GBC01. (036-01s)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Trial of Biphosphonates as Adjuvant Therapy for Primary Breast Cancer (SWOG S0307)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Randomized Trial of Neoadjuvant Therapy for Patients with Palpable and Operable HER2-Positive Breast Cancer, with Correlative Studies to Identify Predictors of Pathologic Complete Response. (NSABP-41)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer. (NSABP P-2)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Trial Comparing Anastrozole and Tamoxifen in Postmenopausal Patients with Breast Cancer (Ductal Cancer in Situ) who are undergoing Lumpectomy and Radiation Therapy (NSABP B-35)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
Psychosocial Outcomes in Adolescent Cancer Survivors (276-05)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Randomized Trial of Maintenance Chemotherapy Comparing 12, Monthly Cycles of Single Agent Paclitaxel or Xyotax (CT-2103), Versus No Treatment in Women with Advanced Ovarian Cancer who have a Complete Response to Initial Chemotherapy (GOG 212)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Molecular Staging Study of Endometrial Carcinoma (GOG 210)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Trial of Triple Therapy (Doxorubicin/Cisplatin/Paclitaxel) and G-CSF versus Double Therapy (Carboplatin/Paclitaxel) in Women with Stage III or IV, or Recurrent, Endometrial Cancer (GOG 209)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Trial of Two Schedules of Perifosine in Subjects with Breast Cancer for whom No Standard Therapy Exists (256-05)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Phase II Trial to Assess the Safety and Efficacy of Hormonal Ablation plus Estramustine & Docetaxel Combined with Radiotherapy in Locally Advanced or Recurrent, Prostate Cancer (258-05)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Randomized Trial Comparing Treatment with Pegylated Liposomal Doxorubicin or Capecitabine as Initial Chemotherapy for Metastatic Breast Cancer in Women 60 Years and Older (265-05)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Phase III Study of Neoadjuvant Therapy in Patients with Operable Breast Cancer, Attempting to Identify Predictors of the Likelihood of a Clinical Response to each Regimen (NSABP B-40)
Currently enrolling additional patients: Yes Clinical Trial Details |
|
A Retrospective review of Bevacizumab (Avastin) and Albumin Bound Paclitaxel (Abraxane) Treatment in Metastatic Breast Cancer (392-06CR)
Currently enrolling additional patients: No Clinical Trial Details |
|
An Open-label Study of IV RPR109881 in patients with Metastatic Breast Cancer, after Treatment with standard Therapies (anthracyclines, taxanes and capecitabine) (217-04)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Multicenter, Phase III, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Bevacizumab in Combination with Chemotherapy Regimens in Subjects with Previously Untreated Metastatic Breast Cancer (317-05)
Currently enrolling additional patients: No Clinical Trial Details |
|
High Dose Chemotherapy for Young Women with High Risk Breast Cancer. (063-97)
Currently enrolling additional patients: No Clinical Trial Details |
|
GeneSearch Breast Lymph Node Assay for Intraoperative Molecular Testing (223-04s)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Study of Sunitinib Malate as a Single Agent for the Treatment of Women with Advanced Breast Cancer. (468-07)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Randomized Study Comparing rhe Combination of Pazonib AND Lapatinib vs. Lapatinib ALONE is Patients with certain types of Inflammatory Breast Cancer (469-07)
Currently enrolling additional patients: No Clinical Trial Details |
|
Micrometastases and Prognosis in Colorectal Carcinoma. (055-99)
Currently enrolling additional patients: No Clinical Trial Details |
|
Fertility Drugs and Ovarian, Endometrial, and Breast Cancer: A Multi-Institutional Study (044-95)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Phase II Evaluation of Weekly Topotecan Hydrochloride (Hycamtin, NSC #609699) in the Treatment of Persistent or Recurrent Carcinoma of the Cervix (GOG 127U)
Currently enrolling additional patients: No Clinical Trial Details |
|
Acquisition of Excess Humor Tumor Tissue Specimens to Study the Biologic Effects of Signal Transduction Inhibitors (555-08)
Currently enrolling additional patients: No Clinical Trial Details |
|
Phase III Comparison of Adjuvant Chemotherapy With or Without Endocrine Therapy in High-Risk, Node-Negative Breast Cancer Patients, and a Natural History Follow-up Study in Low-Risk, Node-Negative Patients (SWOG 8897)
Currently enrolling additional patients: No Clinical Trial Details |
|
Selenium and Vitamin E Prostate Cancer Prevention Trial (SELECT). (S0000)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Trial in Post-menopausal Women with Hormone Receptor Positive Breats Cancer to Determine the Effectiveness of Letrozole compared to Placebo when given for 5 years to Subjects who have Completed 5 years of Therapy with Tamoxifen followed by an Aromatase (NSABP B-42)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Trial of Chemotherapy (Doxorubicin/Cisopatlin/Paclitaxel and G-CSF) vs. Hormonal Therapy (Tamoxifen/Megestrol Acetate) in Patients with Advanced or Recurrent Endometrial Cancer. (GOG 189)
Currently enrolling additional patients: No Clinical Trial Details |
|
Phase II Study of Faslodex in Recurrent/Metastatic Endometrial Cancer (GOG 188)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Study of Paclitaxel for Ovarian Stromal Tumors as First-Line or Second-Line Therapy. (GOG 187)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Study of Tumor Volume Directed Pelvic Plus or Minus Para-Aortic Irradiation by Cisplatin and Doxorubicin or Cisplatin, Doxorubicin and Paclitaxel for Advanced Endometrial Carcinoma. (GOG 184)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Trial of Intense Chemotherapy (through Interval Compression) in Patients with Ewing Sarcoma and Related Tumors. (COG AEWS0031)
Currently enrolling additional patients: No Clinical Trial Details |
|
Expression of the MN Protein in Atypical Glandular Cells of Undetermined Significance (AGUS or AGCUS) as a Potential Predictor of Cervical Cancer (GOG 171)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Trial Comparing Docetaxel in Combination with Doxorubicin and Cyclophosphamide (TAC) vs. Doxorubicin and Cyclophosphamide Followed by Docetaxel (AC-T) as Adjuvant Treatment of Operable Breast Cancer Patients with Positive Axillary Lymph Nodes. (BCIRG 005)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Phase III Intergroup Protocol for the Treatment of Children with Hepatoblastoma. (COG P9645)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Study of Vincristine, Actinomycin-D, and Cyclophosphamide (VAC) vs. VAC Alternating with Vincristine, Topotecan and Cyclophosphamide for Patients with Intermediate Risk Rhabdomyosarcoma. (COG D9803)
Currently enrolling additional patients: No Clinical Trial Details |
|
Randomized Comparison Between Antibiotics Alone and Antibiotics Plus Granulocyte-Colony-Stimulating Factor in Pediatric Patients with Fever and Chemotherapy Induced Neutropenia. (COG AS973)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Study of Aerosolized GM-CSF in patients with a first Pulmonary Recurrence of Osteosarcoma (COG AOST0221)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Pilot Study of Low-Dose Antiangiogenic Chemotherapy in Combination with Standard Multiagent Chemotherapy for Patients with Newly diagnosed Metastatic Ewings Sarcoma (COG AEWS02P1)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Phase II Study of Gemcitabine in Children with Relapsed Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia. (COG ADVL0022)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Study for the Treatment of Newly Diagnosed Disseminated Lymphoblastic Lymphoma or Localized Lymphoblastic Lymphoma. (COG A5971)
Currently enrolling additional patients: No Clinical Trial Details |
|
Treatment for Infants and Children with Intermediate Risk Neuroblastoma. (COG A3961)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Case-Control Study of Risk Factors for Wilms' Tumor. (COG A0026)
Currently enrolling additional patients: No Clinical Trial Details |
|
A Trial of Paclitaxel and Carboplatin vs. Triplet or Sequential Doublet Combination in Patients with Epithelial Ovarian or Primary Peritoneal Carcinoma. (GOG 182)
Currently enrolling additional patients: No Clinical Trial Details |
